Trade Vaxcyte Inc - PCVX CFD
Add to favourite- Summary
- Historical Data
| Spread | 0.11 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023624% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001401% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 35.18 |
| Open | 34.92 |
| 1-Year Change | -45.13% |
| Day's Range | 34.82 - 36.58 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| May 2, 2025 | 35.33 | 0.18 | 0.51% | 35.15 | 36.63 | 34.72 |
| May 1, 2025 | 35.18 | -0.05 | -0.14% | 35.23 | 35.48 | 31.22 |
| Apr 30, 2025 | 35.79 | 1.84 | 5.42% | 33.95 | 36.17 | 33.95 |
| Apr 29, 2025 | 34.71 | 2.11 | 6.47% | 32.60 | 34.84 | 31.95 |
| Apr 28, 2025 | 32.81 | 0.64 | 1.99% | 32.17 | 33.91 | 32.17 |
| Apr 25, 2025 | 32.89 | -0.32 | -0.96% | 33.21 | 33.92 | 31.90 |
| Apr 24, 2025 | 34.38 | 1.51 | 4.59% | 32.87 | 34.45 | 32.30 |
| Apr 23, 2025 | 33.07 | 1.11 | 3.47% | 31.96 | 34.30 | 31.95 |
| Apr 22, 2025 | 31.18 | 0.44 | 1.43% | 30.74 | 32.20 | 30.73 |
| Apr 21, 2025 | 30.35 | 0.09 | 0.30% | 30.26 | 31.51 | 29.95 |
| Apr 17, 2025 | 30.60 | 1.70 | 5.88% | 28.90 | 30.61 | 28.67 |
| Apr 16, 2025 | 29.06 | -0.80 | -2.68% | 29.86 | 29.86 | 28.51 |
| Apr 15, 2025 | 30.18 | -1.27 | -4.04% | 31.45 | 32.62 | 29.20 |
| Apr 14, 2025 | 31.99 | 0.04 | 0.13% | 31.95 | 32.43 | 30.97 |
| Apr 11, 2025 | 31.14 | 3.48 | 12.58% | 27.66 | 31.18 | 27.66 |
| Apr 10, 2025 | 27.98 | -1.27 | -4.34% | 29.25 | 29.54 | 27.58 |
| Apr 9, 2025 | 30.70 | 0.60 | 1.99% | 30.10 | 32.26 | 27.71 |
| Apr 8, 2025 | 30.07 | -3.03 | -9.15% | 33.10 | 33.15 | 28.41 |
| Apr 7, 2025 | 32.44 | 1.99 | 6.54% | 30.45 | 33.97 | 30.40 |
| Apr 4, 2025 | 31.46 | 1.51 | 5.04% | 29.95 | 33.17 | 29.52 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Vaxcyte, Inc. Company profile
About Vaxcyte Inc
Vaxcyte Inc. is a vaccine company, which is focused on developing vaccines designed to prevent or treat common and deadly infectious diseases worldwide. Its cell-free protein synthesis platform enables it to design and produce protein carriers and antigens. Its pipeline includes VAX-24, VAX-XP, VAX-A1 and VAX-PG. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine (PCV). The Company's second PCV candidate, VAX-XP, uses its modular platform and builds on the technical proof of concept established by VAX-24. VAX-A1 is a conjugate vaccine being developed for group A strep infections. Its VAX -PG is being developed as a protein vaccine for the treatment of periodontitis.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Vaxcyte Inc revenues was not reported. Net loss increased 12% to $100.1M. Higher net loss reflects General and administrative - Balancing increase of 49% to $18.5M (expense), Stock-based Compensation in SGA increase of 90% to $6.8M (expense), Stock-based Compensation in R&D increase from $1.9M to $4M (expense).
| Industry: | Bio Therapeutic Drugs |
825 Industrial Road, Ste. 300
SAN CARLOS
CALIFORNIA 94070
US
News
GME shares price forecast: Third-party price target
Read our GameStop (GME) share price forecast for 2025 and beyond, with insights from third-party analysts and market experts
11:40, 28 April 2025
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com